US$ 25.56
ghk-cu peptide tolerance desensitization long-term use The Effect of the Human GHK on Gene Expression Relevant to Nervous System Function and Cognitive Decline If You Stop GHK-Cu What
Description
NMDARs also have much slower kinetics than AMPARs

They should be manufactured in a controlled setting

The most common starting point is 250 mcg twice daily, totaling 500 mcg per day

The MHRA has not licensed AOD 9604 as a medicinal product in the UK, and its status can be confirmed via the MHRA's product licence search
